Related Experiment Video

Updated: Jul 9, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

ACOG Committee Opinion No. 393, December 2007. Newborn screening

    Obstetrics and Gynecology
    |December 7, 2007
    PubMed

    Insights

    Newborn screening tests identify infants with serious health conditions for early diagnosis and treatment. These public health programs ensure timely follow-up and evaluation, benefiting newborns and their families.

    Area of Science:

    • Public Health
    • Pediatrics
    • Genetics

    Background:

    • Newborn screening is a crucial public health initiative.
    • Early detection of congenital disorders is vital for infant health.
    • Timely intervention significantly improves outcomes for affected infants.

    Framework:

    • State programs require robust systems for notification and follow-up of infants with positive screening results.
    • Standardized protocols ensure consistent evaluation of screening outcomes.

    Implementation:

    • Effective implementation involves coordinated efforts between healthcare providers and state public health agencies.
    • Timely follow-up mechanisms are essential to connect infants with necessary diagnostic and treatment services.

    Implications:

    • Newborn screening programs yield substantial public health benefits by identifying at-risk infants.
    • Early intervention facilitated by screening improves long-term health outcomes for affected children.

    More Related Videos

    Biochemical Measurement of Neonatal Hypoxia13:13

    Biochemical Measurement of Neonatal Hypoxia

    Published on: August 24, 2011

    Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

    Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

    Published on: September 6, 2017

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Standards of Care II01:19

    Standards of Care II

    Nurses bear specific legal responsibilities under several federal statutes, including: